chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Suspected COVID-19, Vaccination failure
Clinical narrative: SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 48 year old (age at the time of vaccination 47 year old), female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: 19-SEP-2021) dose was not reported,1 total was administered on 01-APR-2021 on right arm for prophylactic vaccination. No concomitant medications were reported.  On 11-JAN-2022, the patient had symptoms of sore throat, congestion, cough, headache, tiredness and had a fever but no fever for 2 days prior to this report (suspected covid-19 infection). The patient was treating symptoms with unspecified medicine. The congestion was annoying. The patient had these symptoms for a week and was starting to get better. On 13-JAN-2022, the patient tested negative after the symptoms started and on 17-JAN-2022, the patient tested positive with rapid/home test (suspected clinical vaccination failure). On 13-JAN-2022, Laboratory data included: COVID-19 virus test (NR: not provided) Negative. On 17-JAN-2022, Laboratory data included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from suspected covid-19 infection, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report is associated with Product Quality Complaint: 90000212614.; Sender's Comments: V0: 20220133026-COVID-19 VACCINE AD26.COV2.S-suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Sex: M
Vaccine: COVID19
Symptoms: Suspected COVID-19, Vaccination failure
Clinical narrative: SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a 31 year old white male patient of unspecified ethnicity. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 202A21A and expiry: 21-SEP-2021) 1 total, dose was not reported administered at left arm on 12-APR-2021 for prophylactic vaccination.  No concomitant medications were reported.  On an unspecified date, the patient had symptoms of covid after receiving the Janssen covid 19 vaccine (suspected covid-19 infection and suspected clinical vaccination failure) (all events in dose number series 1).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The patient had not recovered from suspected covid-19 infection and the outcome of suspected clinical vaccination failure was not reported. On 08-NOV-2021, the patient received additional booster dose of non-company vaccine included: mrna 1273 (Moderna) (dose number in series 2) (form of admin and route of admin were not reported, batch number: 939f21a, expiry: unknown) 1 total, dose was not reported administered at left arm for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with dose of mrna 1273 (dose number in series 2).  This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000213038.; Sender's Comments: V0 - 20220137153- covid-19 vaccine ad26.cov2.s -Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Pain in extremity, SARS-CoV-2 test, Vaccination failure
Clinical narrative: ARM SORENESS; CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 37 year (age at the time of primary vaccination was 36 year) old white and non Hispanic or Latino male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, 1 total, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced arm soreness which was like any type of shot in that area (Dose number in series 1), The patient received booster dose of mrna 1273 (Moderna) vaccine (Dose number in series 2) (form of admin, route of admin, batch number and expiry date were not reported) dose was not reported, administered on 08-DEC-2021 for prophylactic vaccination. On 17-JAN-2022, the patient experienced minor congestion and light cough and tested positive for COVID-19 at home test (Dose number in series 1). Then he went to his doctor office and took a saliva PCR (polymerase chain reaction) test and received the positive results on 19-JAN-2022 (confirmed clinical vaccination failure, and confirmed covid-19 infection) (Dose number in series 1). Laboratory data included: COVID-19 PCR test (NR: not provided) positive, and COVID-19 rapid POC test (NR: not provided) positive (Dose number in series 1). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the arm soreness, confirmed covid-19 infection and confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000212981. Sender's Comments: V0:20220137673-COVID-19 VACCINE AD26.COV2.S-Confirmed clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Suspected COVID-19, Vaccination failure
Clinical narrative: SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a male of unspecified age, race and ethnicity. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: unknown) dose was not reported,1 total administered on 15-JUL-2021 for prophylactic vaccination on left arm. No concomitant medications were reported. On 19-JAN-2022, the patient was having body aches and headaches (suspected covid-19 infection). On 20-JAN-2022, laboratory data included: COVID-19 antigen test (NR: not provided) Positive, the patient experienced suspected clinical vaccination failure.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint number 90000213492.; Sender's Comments: V0:20220139481 -COVID-19 VACCINE AD26.COV2.S- Suspected clinical Vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Sex: M
Vaccine: COVID19
Symptoms: Headache, Movement disorder, Pain in extremity, Suspected COVID-19, Vaccination failure
Clinical narrative: SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; COULD NOT MOVE ARM; LEFT ARM PAIN; HEADACHE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21N, expiry: UNKNOWN) dose was not reported, 1 total, administered on 18-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced suspected clinical vaccination failure, suspected covid-19 infection which further explained as the patient did not undergo clinical testing for diagnostic confirmation. The patient experienced fever, cough, and body aches. The reporter also noted that after initially received the vaccination patient developed a headache that lasted for 2 months and left arm pain such that he could not move his arm for 2 months. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from left arm pain, headache and the outcome of suspected covid-19 infection, suspected clinical vaccination failure and could not move arm was not reported. This report was serious (Other Medically Important Condition). This case was associated with product quality complaint number 90000213691. This case, from the same reporter is linked to 20220139528 and 20220139639.; Sender's Comments: V0-20220139854-Covid-19 vaccine ad26.CoV-2.s- Suspected clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: TESTED POSITIVE FOR COVID-19; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 19-SEP-2021) dose was not reported, administered on 21-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 20-JAN-2022, the patient experienced tested positive for covid-19. Laboratory data included: COVID-19 rapid POC test (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of tested positive for covid-19 was not reported. This report was non-serious.; Sender's Comments: V0; Medical assessment comment not required as per standard procedure as case assessed as non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Suspected COVID-19, Vaccination failure
Clinical narrative: SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 36 year old white male of unspecified ethnicity. Initial information processed with additional information received on 21-JAN-2022. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: unknown expiry: unknown) dose was not reported, 1 total, administered on 08-JUL-2021 at left arm for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient had symptoms of covid (suspected covid-19 infection and suspected clinical vaccination failure). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from suspected covid-19 infection, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with regulatory authority. This case, involving the same patient is linked to 20220141644.; Sender's Comments: V0: 20220140123-covid-19 vaccine ad26.cov2.s-suspected clinical vaccination failure . This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Suspected COVID-19, Vaccination failure
Clinical narrative: SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 50 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, expiry: UNKNOWN) dose was not reported, 1 total administered for left arm on 05-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 17-JAN-2022, the patient experienced headache, nasal congestion (suspected covid-19 infection) On 18-JAN-2022, the patient tested positive for Covid-19 with an Abbot home kit test (suspected clinical vaccination failure).The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected clinical vaccination failure and suspected covid-19 infection was not reported. This report was serious (Other Medically Important Condition). This report was associated with regulatory authority.; Sender's Comments: V0: 20220140177-JANSSEN COVID-19 VACCINE Ad26.COV2.S- SUSPECTED CLINICAL VACCINATION FAILURE. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.
Sex: M
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: SEIZURES; This spontaneous report received from a consumer concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose and start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced seizures. The reporter stated patient had seizures daily. Later, on a n unspecified date, the patient got hospitalized for seizures. The patient was hospitalized for 4 months (number of days was not specified).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of seizures was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20220140223-Covid-19 vaccine ad26.cov2.s-Seizures. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Sex: M
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: HAIR LOSS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient had no known allergies. The patient never had covid previously. On 18-NOV-2020, the patient received covid-19 vaccine ad26.cov2.s (dose number in series: 1) (suspension for injection, route of admin not reported, batch number were not reported) dose was not reported, 1 total administered for prophylactic vaccination. No adverse events were reported following covid-19 vaccine ad26.cov2.s (Dose number in series: 1). On 23-DEC-2021, the patient received covid-19 vaccine ad26.cov2.s (dose number in series: 2) (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total administered to right deltoid for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 05-JAN-2022, the patient noticed having hair loss which started out small just round the hairline and then a couple of days later, became more significant in a line all the way to the front of the hairline. On an unspecified date, the patient had visited the healthcare professional office (Dose number in series: 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hair loss. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: TESTED POSITIVE FOR COVID-19; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was not pregnant at the time of event. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 21-SEP-2021) dose was not reported, administered on 15-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-JAN-2022, the patient experienced tested positive for covid-19. Laboratory data included: COVID-19 virus test (not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of tested positive for covid-19 was not reported. This report was non-serious. This case is associated with a product quality complaint: Sender's Comments: V2-Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Joint swelling, Myalgia
Clinical narrative: This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: autoimmune disease Sojourn's disease. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 03-DEC-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced joint swelling in hands, fast heart beat, palpitation, body ache, muscle ache, and headache. Laboratory data (dates unspecified) included: Heart rate (NR: not provided) fast. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the joint swelling in hands, fast heart beat, palpitation, body ache, muscle ache, and headache was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Palpitations
Clinical narrative: This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: autoimmune disease Sojourn's disease. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 03-DEC-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced joint swelling in hands, fast heart beat, palpitation, body ache, muscle ache, and headache. Laboratory data (dates unspecified) included: Heart rate (NR: not provided) fast. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the joint swelling in hands, fast heart beat, palpitation, body ache, muscle ache, and headache was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: ARM HURTS LIKE HELL; JOINTS ACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced arm hurts like heck, and joints ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from arm hurts like hell, and the outcome of joints ache was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Nervous system disorder, Tremor
Clinical narrative: This spontaneous report received from a consumer via a company representative concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced uncontrollable nervous system, and can't quit shaky. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the uncontrollable nervous system and can't quit shaky was not reported. This report was non-serious.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Pruritus, Rash
Clinical narrative: Site: Itching at Injection Site-Mild, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash Generalized-Medium
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient had 3rd dose of Pfizer Covid-19 vaccine. Sat with mom and apparrently fainted. Nurse from clinic alerted us to call the ambulance per mom's request. I called emergency number and requested ambulance. I then went over to see the patient at the time she was sitting in the chair and was responsive, but the mom said she had fainted and they alerted the nurse. The patient was then moved into a room in the clinic where she could lay back. The patient was able to ambulate on her own.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Nausea-Medium
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain, Injection site swelling, Limb injury, Paraesthesia
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-, Additional Details: patient says shot was given too high and thinks it was given in the bursa, this has caused a lot of sweeling and pain.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered at inappropriate site
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-, Additional Details: patient says shot was given too high and thinks it was given in the bursa, this has caused a lot of sweeling and pain.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Chest pain, Dyspepsia, Lymphadenopathy
Clinical narrative: Presented with full body urticaria starting in the palms, wrists, neck, groin, and ankles. Extremely itchy welts persisted so visited a walk in clinic the next day, was told "your body came into contact with something it really didn't like" and was prescribed 5 days of prednisone. Symptoms got much worse that night, so revisited the clinic again and was subsequently prescribed Hydroxyzine and recommended to take Claritin and Famotidine. After starting antihistamines and finishing steroids, the full body hives subsided for the most part, with random flare ups each day that go away over the course of a couple hours. Developed skin writing (Dermatographia) at about day 2 of onset of symptoms and still persists regardless of antihistamine use. The slightest scratch or even rubbing of my clothes or glasses against my skin causes lines. I can draw pictures on my skin and welts in the shape of the drawing appear within a minute and disappear within the course of about 30 minutes or so. Rubbing of my eyes or lips, and cleaning of my vuvla in the shower also seems to cause a swelling reaction. At the beginning and height of my symptoms I also experienced widespread joint pain, swelling of lymphnodes in the neck and armpit, and even suspected swelling of salivary glands that made it painful to move my jaw or chew. Also experienced bad heartburn and chest pain and tightness, although that could have been a side effect of the steroids as it mostly subsided after discontinuing use.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Mechanical urticaria, Pain, Pruritus, Salivary gland enlargement, Swelling
Clinical narrative: Presented with full body urticaria starting in the palms, wrists, neck, groin, and ankles. Extremely itchy welts persisted so visited a walk in clinic the next day, was told "your body came into contact with something it really didn't like" and was prescribed 5 days of prednisone. Symptoms got much worse that night, so revisited the clinic again and was subsequently prescribed Hydroxyzine and recommended to take Claritin and Famotidine. After starting antihistamines and finishing steroids, the full body hives subsided for the most part, with random flare ups each day that go away over the course of a couple hours. Developed skin writing (Dermatographia) at about day 2 of onset of symptoms and still persists regardless of antihistamine use. The slightest scratch or even rubbing of my clothes or glasses against my skin causes lines. I can draw pictures on my skin and welts in the shape of the drawing appear within a minute and disappear within the course of about 30 minutes or so. Rubbing of my eyes or lips, and cleaning of my vuvla in the shower also seems to cause a swelling reaction. At the beginning and height of my symptoms I also experienced widespread joint pain, swelling of lymphnodes in the neck and armpit, and even suspected swelling of salivary glands that made it painful to move my jaw or chew. Also experienced bad heartburn and chest pain and tightness, although that could have been a side effect of the steroids as it mostly subsided after discontinuing use.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Presented with full body urticaria starting in the palms, wrists, neck, groin, and ankles. Extremely itchy welts persisted so visited a walk in clinic the next day, was told "your body came into contact with something it really didn't like" and was prescribed 5 days of prednisone. Symptoms got much worse that night, so revisited the clinic again and was subsequently prescribed Hydroxyzine and recommended to take Claritin and Famotidine. After starting antihistamines and finishing steroids, the full body hives subsided for the most part, with random flare ups each day that go away over the course of a couple hours. Developed skin writing (Dermatographia) at about day 2 of onset of symptoms and still persists regardless of antihistamine use. The slightest scratch or even rubbing of my clothes or glasses against my skin causes lines. I can draw pictures on my skin and welts in the shape of the drawing appear within a minute and disappear within the course of about 30 minutes or so. Rubbing of my eyes or lips, and cleaning of my vuvla in the shower also seems to cause a swelling reaction. At the beginning and height of my symptoms I also experienced widespread joint pain, swelling of lymphnodes in the neck and armpit, and even suspected swelling of salivary glands that made it painful to move my jaw or chew. Also experienced bad heartburn and chest pain and tightness, although that could have been a side effect of the steroids as it mostly subsided after discontinuing use.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Pain in extremity, Temperature intolerance
Clinical narrative: After the 1st dose on Dec 7, 2021 constant aching in every finger and toe started. Two days after the second shot, got noticeably worse. The shoulder, elbow and knee pain remained the same. Fingers and toes have very low tolerance to cold. Just a few minutes exposure results in excruciating pain. Occasionally have shooting pains through forearms and lower legs. Taking  2 aspirin and 2 Advil every day to ease the pain.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Patient received  5 Through 11 Years of Age Pfizer-BioNTech COVID-19 Vaccine when they should have received Pfizer-BioNTech COVID-19 Vaccine  Age 12 and Over.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Lightheadedness/ Felt Faint Required prolonged observation  Supplemental oxygen administered
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone, Full blood count, Heavy menstrual bleeding, Human chorionic gonadotropin, Oligomenorrhoea
Clinical narrative: Heavy menstrual cycles / prolonged period of bleeding.  Prior to vaccine in October 2021, average time been menses was 28-30 days, with very light bleeding. Now menses begins at any time during the month, with very heavy bleeding.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis
Clinical narrative: Heavy menstrual cycles / prolonged period of bleeding.  Prior to vaccine in October 2021, average time been menses was 28-30 days, with very light bleeding. Now menses begins at any time during the month, with very heavy bleeding.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, Blood creatine increased, COVID-19, COVID-19 pneumonia
Clinical narrative: Patient is fully vaccinated.  Hospitalized on 12/25/2021.  COVID + on 12/25/2021.  91-year-old female patient presented with past medical history of hypertension, chronic pain, dementia, depression, and end-stage renal failure, presented to ED due to rectal bleeding that started today.  The patient is alert and oriented x2, and cannot give a clear history, though she reports that she had dark black rectal bleeding today and has never had this in the past. Assessment/Treatment:  acute GI bleed, HG 7.8 PRBC transfusion, DC heparin, COVID viral pneumonia:  O2 sat 88% CXR Mild worsened aeration of the lung bases.  supplemental oxygen, decadron, remdesivir, AKI: cr 2.16. + for thrombocytopenia.  Patient discharged
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Faeces discoloured, Gastrointestinal haemorrhage, Haemoglobin decreased, Lung disorder
Clinical narrative: Patient is fully vaccinated.  Hospitalized on 12/25/2021.  COVID + on 12/25/2021.  91-year-old female patient presented with past medical history of hypertension, chronic pain, dementia, depression, and end-stage renal failure, presented to ED due to rectal bleeding that started today.  The patient is alert and oriented x2, and cannot give a clear history, though she reports that she had dark black rectal bleeding today and has never had this in the past. Assessment/Treatment:  acute GI bleed, HG 7.8 PRBC transfusion, DC heparin, COVID viral pneumonia:  O2 sat 88% CXR Mild worsened aeration of the lung bases.  supplemental oxygen, decadron, remdesivir, AKI: cr 2.16. + for thrombocytopenia.  Patient discharged
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Packed red blood cell transfusion, Rectal haemorrhage, SARS-CoV-2 test positive, Thrombocytopenia, Total lung capacity decreased
Clinical narrative: Patient is fully vaccinated.  Hospitalized on 12/25/2021.  COVID + on 12/25/2021.  91-year-old female patient presented with past medical history of hypertension, chronic pain, dementia, depression, and end-stage renal failure, presented to ED due to rectal bleeding that started today.  The patient is alert and oriented x2, and cannot give a clear history, though she reports that she had dark black rectal bleeding today and has never had this in the past. Assessment/Treatment:  acute GI bleed, HG 7.8 PRBC transfusion, DC heparin, COVID viral pneumonia:  O2 sat 88% CXR Mild worsened aeration of the lung bases.  supplemental oxygen, decadron, remdesivir, AKI: cr 2.16. + for thrombocytopenia.  Patient discharged
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient received  5 Through 11 Years of Age Pfizer-BioNTech COVID-19 Vaccine when they should have received Pfizer-BioNTech COVID-19 Vaccine  Age 12 and Over.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Diffuse urticarial rash approximately 10 days after Moderna booster.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Rash
Clinical narrative: After first injection, developed itchy skin rash inside elbow left arm (near injection site).  This cleared up in about 6 weeks.  After second injection, developed itchy skin rash on upper left chest (near injection site).  Doctor thought it might be a "contact allergy", administered a steroid injection.  Cleared up for two weeks, then returned and continues to this day (now about 10 months).  I have no known allergies, this is not a contact allergy because it is confined to a specific area on my body.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pruritus, Rash, SARS-CoV-2 test
Clinical narrative: After first injection, developed itchy skin rash inside elbow left arm (near injection site).  This cleared up in about 6 weeks.  After second injection, developed itchy skin rash on upper left chest (near injection site).  Doctor thought it might be a "contact allergy", administered a steroid injection.  Cleared up for two weeks, then returned and continues to this day (now about 10 months).  I have no known allergies, this is not a contact allergy because it is confined to a specific area on my body.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure congestive, Computerised tomogram thorax abnormal, Cough, Dyspnoea
Clinical narrative: Patient is fully vaccinated.  COVID-19 positive on 12/25/2021 on admission to hospital. 93-year-old male with reported cough and shortness of breath. The patient denied any chest pain, abdominal pain, nausea, vomiting or diarrhea. Admission diagnosis: CHF, SOB, elevated troponin and COVID-19. CT PE: Patchy ground glass airspace opacities, peripherally throughout the lungs bilaterally. Findings concerning for underlying atypical viral pneumonitis. No evidence of pulmonary embolism. Treatment: Oxygen, Decadron and Remdesivir. Positive hematuria; no anticoagulation therapy.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Haematuria, Lung opacity, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Patient is fully vaccinated.  COVID-19 positive on 12/25/2021 on admission to hospital. 93-year-old male with reported cough and shortness of breath. The patient denied any chest pain, abdominal pain, nausea, vomiting or diarrhea. Admission diagnosis: CHF, SOB, elevated troponin and COVID-19. CT PE: Patchy ground glass airspace opacities, peripherally throughout the lungs bilaterally. Findings concerning for underlying atypical viral pneumonitis. No evidence of pulmonary embolism. Treatment: Oxygen, Decadron and Remdesivir. Positive hematuria; no anticoagulation therapy.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Lymphadenopathy, Urticaria
Clinical narrative: Diffuse urticarial rash about 1 week after Moderna booster.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: Sore arm + shoulder- got steroid inj into shoulder joint 1/19/22 + started meloxicam po qd-
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Blindness unilateral, Cardiac monitoring normal, Cerebral thrombosis, Computerised tomogram head normal
Clinical narrative: 9/18/21- Patient dev. vertigo for 2 days (1st time ever)  10/10/21 - Patient lost 1/2 of eyesight in left eye due to ARTERIAL RETINA CLOT (permanently).  10/27/21- Patient's G.P. ordered MRI/MRA of head. Diagnosis was an Acute Cerebral Thrombosis discovered in her Brain. Patient was hospitalized for 3 days subjected to numerous tests. To date there have been no lasting effects other than a slight imbalance from the acute brain thrombosis. Patient has a permanent partial loss of SIGHT IN Left EYE.    Second vaccine given 3/11/21 lot # EN6205 Left Arm
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram normal, Echocardiogram, Echocardiogram normal, Laboratory test, Magnetic resonance imaging head abnormal
Clinical narrative: 9/18/21- Patient dev. vertigo for 2 days (1st time ever)  10/10/21 - Patient lost 1/2 of eyesight in left eye due to ARTERIAL RETINA CLOT (permanently).  10/27/21- Patient's G.P. ordered MRI/MRA of head. Diagnosis was an Acute Cerebral Thrombosis discovered in her Brain. Patient was hospitalized for 3 days subjected to numerous tests. To date there have been no lasting effects other than a slight imbalance from the acute brain thrombosis. Patient has a permanent partial loss of SIGHT IN Left EYE.    Second vaccine given 3/11/21 lot # EN6205 Left Arm
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Ophthalmological examination, Retinal artery thrombosis, Vertigo, Visual impairment
Clinical narrative: 9/18/21- Patient dev. vertigo for 2 days (1st time ever)  10/10/21 - Patient lost 1/2 of eyesight in left eye due to ARTERIAL RETINA CLOT (permanently).  10/27/21- Patient's G.P. ordered MRI/MRA of head. Diagnosis was an Acute Cerebral Thrombosis discovered in her Brain. Patient was hospitalized for 3 days subjected to numerous tests. To date there have been no lasting effects other than a slight imbalance from the acute brain thrombosis. Patient has a permanent partial loss of SIGHT IN Left EYE.    Second vaccine given 3/11/21 lot # EN6205 Left Arm
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Diffuse urticarial rash 9 days after Moderna COVID booster.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Bursitis, Injection site bruising, Tendonitis
Clinical narrative: Bruise at injection site. Bursitis.Tendonitis
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal
Clinical narrative: By the end of the day after I received the vaccine I felt exhausted and extreme fatigue similar to the extreme fatigue I experienced when I contracted Covid. Since the vaccination I experience constant fatigue and brain fog.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Severe Sudden onset tinnitus 12 days after for a shot. Has not resolved.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Hyperhidrosis, Hypoaesthesia, Hypotension
Clinical narrative: I started getting hot/sweaty and thought I was either going to pass out or throw up, my heart was racing and both of my hands went completely numb. For about 10 minutes my fingers were cramped in weird positions and I could not move them.  It  was like they were temporarily paralyzed. I seriously thought I was going to have a stroke.  After about 30 minutes I started feeling better and I went to my doctors office.  She checked my blood pressure and it was very low.  I went home and fell asleep.  I woke up a couple hours later and had a fever and felt like I had Covid all over again.  I slept the rest of the day and the next day I felt fine.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Movement disorder, Muscle spasms, Nausea, Neurological symptom, Palpitations
Clinical narrative: I started getting hot/sweaty and thought I was either going to pass out or throw up, my heart was racing and both of my hands went completely numb. For about 10 minutes my fingers were cramped in weird positions and I could not move them.  It  was like they were temporarily paralyzed. I seriously thought I was going to have a stroke.  After about 30 minutes I started feeling better and I went to my doctors office.  She checked my blood pressure and it was very low.  I went home and fell asleep.  I woke up a couple hours later and had a fever and felt like I had Covid all over again.  I slept the rest of the day and the next day I felt fine.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: I started getting hot/sweaty and thought I was either going to pass out or throw up, my heart was racing and both of my hands went completely numb. For about 10 minutes my fingers were cramped in weird positions and I could not move them.  It  was like they were temporarily paralyzed. I seriously thought I was going to have a stroke.  After about 30 minutes I started feeling better and I went to my doctors office.  She checked my blood pressure and it was very low.  I went home and fell asleep.  I woke up a couple hours later and had a fever and felt like I had Covid all over again.  I slept the rest of the day and the next day I felt fine.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Pyrexia, Rhinorrhoea
Clinical narrative: Fever, fatigue, runny nose, dizziness
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Blood test abnormal, COVID-19, Dyspnoea at rest, Headache
Clinical narrative: Breakthrough COVID. First vaccine 3/13/21. Patient is a 60 yo M with history of hypertension. Pt admitted to ED. Pt reports testing positive for COVID19 on 1/17/22 but symptos progrssively worsened. Pt admits to productive cough, headache, and SOB at rest but denies fever, chills, nausea, vomiting, chest pain, diarrhea, abdominal pain, dizziness, body aches or any other symptoms. ED workup included bloodwork that showed hypokalemia and CT Angio Chest revealed "bilat. lower lobe predominant groundglass and airspace infiltrates most in keeping with atypical infection, possibly viral pneumonia."
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypokalaemia, Lung infiltration, Lung opacity, Productive cough, SARS-CoV-2 test positive
Clinical narrative: Breakthrough COVID. First vaccine 3/13/21. Patient is a 60 yo M with history of hypertension. Pt admitted to ED. Pt reports testing positive for COVID19 on 1/17/22 but symptos progrssively worsened. Pt admits to productive cough, headache, and SOB at rest but denies fever, chills, nausea, vomiting, chest pain, diarrhea, abdominal pain, dizziness, body aches or any other symptoms. ED workup included bloodwork that showed hypokalemia and CT Angio Chest revealed "bilat. lower lobe predominant groundglass and airspace infiltrates most in keeping with atypical infection, possibly viral pneumonia."
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID. First vaccine 3/13/21. Patient is a 60 yo M with history of hypertension. Pt admitted to ED. Pt reports testing positive for COVID19 on 1/17/22 but symptos progrssively worsened. Pt admits to productive cough, headache, and SOB at rest but denies fever, chills, nausea, vomiting, chest pain, diarrhea, abdominal pain, dizziness, body aches or any other symptoms. ED workup included bloodwork that showed hypokalemia and CT Angio Chest revealed "bilat. lower lobe predominant groundglass and airspace infiltrates most in keeping with atypical infection, possibly viral pneumonia."
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Dementia, Echocardiogram, Loss of personal independence in daily activities, Magnetic resonance imaging
Clinical narrative: Patient had been living independently prior to vaccine.  But shortly after her first vaccine, she developed increased difficulty with her memory.  Unable to consistently remember how to manage finances, set up regular medications, use new protocols for safety to avoid contracting COVID.  She needed reminders set up through her home.  She developed a hammer finger prompting more support by her family for activities of daily living, which prompted observation of her memory related struggles. She was also unable to follow the instructions for the new hammer finger suggested by ER and the Physical therapy she received. She needed prompts for activities she had previously taken pride in managing all her life.  She was shortly thereafter referred by her PCP for neurological assessment and in April 2021 was diagnosed with Major Cognitive Disorder Vascular Dementia.  She is now in a Memory Care Facility.  These life changing events seemed to come rather suddenly for someone who had no acute medical event prompting a shift from independence to dependence in a relatively short amount of time.  I am not sure if this is causally related to the vaccine or just correlated in time with when the vaccine was received.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Memory impairment, Vascular dementia
Clinical narrative: Patient had been living independently prior to vaccine.  But shortly after her first vaccine, she developed increased difficulty with her memory.  Unable to consistently remember how to manage finances, set up regular medications, use new protocols for safety to avoid contracting COVID.  She needed reminders set up through her home.  She developed a hammer finger prompting more support by her family for activities of daily living, which prompted observation of her memory related struggles. She was also unable to follow the instructions for the new hammer finger suggested by ER and the Physical therapy she received. She needed prompts for activities she had previously taken pride in managing all her life.  She was shortly thereafter referred by her PCP for neurological assessment and in April 2021 was diagnosed with Major Cognitive Disorder Vascular Dementia.  She is now in a Memory Care Facility.  These life changing events seemed to come rather suddenly for someone who had no acute medical event prompting a shift from independence to dependence in a relatively short amount of time.  I am not sure if this is causally related to the vaccine or just correlated in time with when the vaccine was received.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Headache, Myalgia
Clinical narrative: Headache, extremely weak and sore muscles, loss of appetite.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Less than a week after getting my 3rd (booster) vaccination my hands and sometimes my whole body became shaky and it hasn't subsided. The shaking never happened with the first 2 doses.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Condition aggravated
Clinical narrative: Diagnosed with bells?palsy